Karfilzomib

Karfilzomib (868540-17- 4)

Carfilzomib (868540-17-4) Carfilzomib is used in treatment of refractory multiple myeloma. Carfilzomib is associated with a low rate of serum enzyme elevations during treatment and has been implicated to rare instances of clinically apparent, acute liver injury some of which have been fatal. Product Name: Carfilzomib CAS No.: 868540-17-4 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C40H57N5O7 Molecular Weight: 719.92 Shelf Life: 2 Years Package: